Updates
Perspectives and deep dives on the models powering AI for life science discovery.
Updates
This update allows researchers and bioinformaticians to perform rapid protein structure and complex prediction through an integrated, user-friendly workflow on Vecura, eliminating the need for complex local HPC setup.
Updates
This update allows medicinal chemists and researchers to perform comprehensive ADMET profiling on small-molecule libraries through an integrated workflow in Vecura, removing the need for manual model deployment or specialized hardware.
Updates
This update enables antibody researchers and protein engineers to perform de novo antibody and nanobody design through a streamlined, guided workflow on Vecura, eliminating the need for manual configuration of complex structural biology pipelines.
Updates
The integration of NVIDIA's GenMol into the Vecura platform empowers medicinal chemists and drug discovery researchers to perform intelligent, fragment-based molecular design directly through a guided workflow, eliminating the need for complex local infrastructure.
Updates
This update enables researchers and protein engineers to design novel amino acid sequences for custom protein structures through a guided workflow inside Vecura, eliminating the need to manage complex, resource-heavy technical infrastructure.
Updates
This update enables protein designers and structural biologists to generate de novo protein backbones with co-designed sequences conditioned on user-defined 3D ellipsoidal layouts through a guided workflow inside Vecura, without setting up complex technical infrastructure.
Updates
This update enables structural biologists and drug discovery researchers to predict RNA 3D structures from sequence data through a guided workflow inside Vecura, without setting up complex GPU infrastructure or managing multiple dependencies.
Updates
This update enables researchers, bioinformaticians, and drug discovery scientists to analyze genetic variants, optimize codon sequences, and assess coding sequence fitness through a guided workflow inside Vecura, without setting up complex technical infrastructure.
Updates
This update enables medicinal chemists, drug-discovery researchers, and computational scientists to generate novel, chemically valid 3D small molecules from scratch through a guided workflow inside Vecura, without setting up complex GPU infrastructure or managing pretrained model weights.
Updates
This update enables synthetic biologists and drug discovery researchers to generate high-affinity de novo protein binders through a streamlined workflow inside Vecura, eliminating the need for managing complex GPU-intensive infrastructure.
Updates
This update enables structural biologists and researchers to generate diverse 3D protein conformational ensembles directly within Vecura, simplifying the study of protein dynamics without requiring complex local infrastructure or high-performance computing setups.
Updates
This update enables drug discovery researchers and structural biologists to predict and visualize complex protein-ligand binding poses through a streamlined, high-performance workflow inside Vecura, removing the need for complex infrastructure setup.